Abstract
Objectives
Since the pituitary gland measures 3-8 mm, imaging with the highest possible spatial resolution is important for the detection of even smaller lesions such as those seen in Cushing's disease. In the current feasibility study, we tested a multi-sequence MRI protocol to visualize the pituitary gland in high resolution at 7.0 Tesla (7.0 T).
Methods
Ten healthy volunteers were examined with a 7.0 T pituitary gland protocol. The protocol consisted of a T1-weighted magnetization-prepared inversion recovery (MPIR) turbo spin-echo (TSE) sequence and a T2-weighted TSE sequence. Additionally, this protocol was tested in five patients with clinical and biochemical suspicion of a microadenoma.
Results
The dedicated protocol was successful in visualizing normal pituitary anatomy. At 7.0 T compared to 1.5 T, four times as many slices covered the pituitary gland in sagittal and coronal direction. In three patients, a lesion was diagnosed at 7.0 T, and was confirmed by histopathology to be a microadenoma.
Conclusion
Head-to-head comparisons of 7.0 T with 1.5 T and 3.0 T are needed with larger samples of patients and with imaging times feasible for clinical settings. However, the current study suggests that high-resolution 7.0 T MRI of the pituitary gland may provide new perspectives when used as a second-line diagnostic examination in the specific context of Cushing's disease.
Key Points
• 7.0 T MRI enables ultra-high-resolution imaging of the pituitary gland.
• 7.0 T MRI is appropriate to visualize normal pituitary gland anatomy.
• The pituitary protocol consists of a T 1 -MPIR-TSE and a T 2 -TSE sequence.
• In four patients, a suspected ACTH-producing microadenoma was visualized at 7.0 T.
• Histopathology confirmed three of four lesions to be ACTH-producing microadenomas.
Abbreviations
- ACTH :
-
Adrenocorticotropic hormone
- CNR :
-
Contrast-to-noise ratio
- IRB :
-
Institutional review board
- MPIR :
-
Magnetization-prepared inversion recovery
- MRI :
-
Magnetic resonance imaging
- SAR :
-
Specific absorption rate
- SNR :
-
Signal-to-noise ratio
- T :
-
Tesla
- TFE :
-
Turbo field echo
- TSE :
-
Turbo spin echo
References
Escourolle H, Abecassis JP, Bertagna X et al (1993) Comparison of computerized tomography and magnetic resonance imaging for the examination of the pituitary gland in patients with Cushing's disease. Clin Endocrinol (Oxf) 39:307–313
Dwyer AJ, Frank JA, Doppman JL et al (1987) Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. Radiology 163:421–426
Shah S, Waldman AD, Mehta A (2012) Advances in pituitary imaging technology and future prospects. Best Pract Res Clin Endocrinol Metab 26:35–46
Kim LJ, Lekovic GP, White WL, Karis J (2007) Preliminary experience with 3-Tesla MRI and Cushing's disease. Skull Base 17:273–277
Wolfsberger S, Ba-Ssalamah A, Pinker K et al (2004) Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions. J Neurosurg 100:278–286
Plewes DB, Kucharczyk W (2012) Physics of MRI: a primer. J Magn Reson Imaging 35:1038–1054
Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19:647–672
Pinker K, Ba-Ssalamah A, Wolfsberger S, Mlynarik V, Knosp E, Trattnig S (2005) The value of high-field MRI (3 T) in the assessment of sellar lesions. Eur J Radiol 54:327–334
Runge VM, Patel MC, Baumann SS et al (2006) T1-weighted imaging of the brain at 3 tesla using a 2-dimensional spoiled gradient echo technique. Invest Radiol 41:68–75
Krautmacher C, Willinek WA, Tschampa HJ et al (2005) Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T–Initial Experience. Radiology 237:1014–1019
Sasaki M, Inoue T, Tohyama K, Oikawa H, Ehara S, Ogawa A (2003) High-field MRI of the central nervous system: current approaches to clinical and microscopic imaging. Magn Reson Med Sci 2:133–139
Kakite S, Fujii S, Kurosaki M et al (2011) Three-dimensional gradient echo versus spin echo sequence in contrast-enhanced imaging of the pituitary gland at 3 T. Eur J Radiol 79:108–112
Erickson D, Erickson B, Watson R et al (2010) 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome. Clin Endocrinol (Oxf) 72:793–799
Stobo DB, Lindsay RS, Connell JM, Dunn L, Forbes KP (2011) Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours. Clin Endocrinol (Oxf) 75:673–677
Soher BJ, Dale BM, Merkle EM (2007) A review of MR physics: 3 T versus 1.5 T. Magn Reson Imaging Clin N Am 15:277–290
van der Kolk AG, Zwanenburg JJ, Brundel M et al (2011) Intracranial vessel wall imaging at 7.0-T MRI. Stroke 42:2478–2484
van der Kolk AG, Hendrikse J, Brundel M et al (2013) Multi-sequence whole-brain intracranial vessel wall imaging at 7.0 tesla. Eur Radiol 23:2996–3004
Wisse LE, Gerritsen L, Zwanenburg JJ et al (2012) Subfields of the hippocampal formation at 7 T MRI: in vivo volumetric assessment. Neuroimage 61:1043–1049
Wezel J, Kooij BJ, Webb AG (2013) Assessing the MR compatibility of dental retainer wires at 7 Tesla. Magn Reson Med
Scangas GA, Laws ER Jr (2013) Pituitary incidentalomas. Pituitary
Acknowledgements
The scientific guarantor of this publication is J. Hendrikse. The authors of this manuscript declare relationships with the following companies: Philips Healthcare, Best, the Netherlands. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: primarily prospective, diagnostic or prognostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Rotte, A.A.J., van der Kolk, A.G., Rutgers, D. et al. Feasibility of high-resolution pituitary MRI at 7.0 tesla. Eur Radiol 24, 2005–2011 (2014). https://doi.org/10.1007/s00330-014-3230-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-014-3230-x